Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy?: The 1988 robert wartenberg lecture

Neurology

Volumn 39, Issue 1, 1989, Pages 111-118

  Dyck, Peter James ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; HISTOLOGY; HUMAN; HYPOXIA; POLYNEUROPATHY; PRIORITY JOURNAL; REVIEW; ULTRASTRUCTURE;

ANIMAL; ANOXIA; ARTERIAL OCCLUSIVE DISEASES; BIOMECHANICS; DIABETIC NEUROPATHIES; HUMAN; ISCHEMIA; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NERVE FIBERS; PERIPHERAL NERVES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024508255     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.39.1.111     Document Type: Article

References (84)

1. Dyck PJ, Thomas PK, Lambert EH, Bunge R. Peripheral neuropathy, 2nd ed., vols 1 and 2. Philadelphia: W.B. Saunders, 1984.
2. Thomas PK, Ochoa J. Microscopic anatomy of peripheral nerve fibers. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, 2nd ed., vol 1. Philadelphia: W.B. Saunders, 1984:39–96.
3. Low PA. Endoneurial fluid pressure and microenvironment of nerve. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, 2nd ed., vol 1. Philadelphia: W.B. Saunders, 1984:599–618.
4. Berthold C-H, Carlstedt T, Corneliuson O. Anatomy of the nerve root at the central-peripheral transitional region. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, 2nd ed., vol 1. Philadelphia: W.B. Saunders, 1984:156–170.
5. Olsson Y. Vascular permeability in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, Bunge E, eds. Peripheral neuropathy, 2nd ed., vol 1. Philadelphia: W.B. Saunders, 1984:579–597.
6. Lapinsky M. Ueber Veranderungen der Nerven bei acuter Storund der Blutzufuhr. Dtsch Z Nervenheilkd 1899;15:364–394.
7. Blackwood W. A patholofzist looke- at ischaemia. Edinburgh Med J 1944;51:131–143.
8. Gairns FW, Garven HSD, Smith G. The digital nerves and the nerve endings in progressive obliterative vascular diseaae of the leg. Scott Med J 1960;5:382–391.
9. Karpati G, Carpenter S, Melmed C, Eisen AA. Experimental ischemic myopathy. J Neurol Sci 1974;23:129–161.
10. Kussmaul A, Maier R. Ueber eine bisher nicht beschriebene eigenthumliche Arterienerkrankung (Periarteritis nodoaa), die mit Morbus Brightii und rapid fortachmitender allgemeiner Mus-kellahmung einhergeht. Deutsches Arch Klin Med 1866;1:484–518.
11. Dutil A, Lamy H. Contribution a l’etude de I’arthrite obliterante progressive: et des névrita d’origine vasculaire. Arch Med Exp Anat Pathol 1893;5:102–120.
12. Joffroy A, Achard C. Névrite périphérique: d’origine vasculaire. Arch Med Exp Anat Pathol 1889;1:229–240.
13. Dreyh PM, Hakim S, Adams RD. Diabetic ophthalmoplegia: report of case, with postmortem study and comments on vascular supply of human oculomotor nerve. AMA Arch Neurol Psychiatry 1957;77:337–349.
14. Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 1970;93:555–566.
15. Rd MC, Sangalang V, Asbury AK. Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol 1968;18:487–499.
16. Dyck PJ, Conn DL, Okazaki H. Necrotizing angiopathic neuropathy: three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc 1972;47:461–475.
17. Johnson PC, Doll SC, Cromey DW. Pathogenesis of diabetic neuropathy. Ann Neurol 1986;19:450–457.
18. Korthals JK, Wisniewski HM. Peripheral nerve ischemia, part 1: experimental model. J Neurol Sci 1975;24:65–76.
19. Korthals JK, Korthals MA, Wisnieweki HM. Peripheral nerve iechemia, part 2 accumulation of organelk Ann Neurol 1978;4:487–498.
20. Hesa K, Eames RA, Darveniza P, Gilliatt RW. Acute ischaemic neuropathy in the rabbit. J Neurol Sci 1979;44:19–43.
21. Parry GJ, Brown MJ. Selective fiber vulnerability in acute ischemic neuropathy. Ann Neurol 1982;11:147.
22. Nukada H, Dyck PJ. Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination. Ann Neurol 1987;22:311–318.
23. Nukada H, Dyck PJ. The three-dimensional distribution of nerve damage from microsphere embolization of nerve capillaries. J Neurosci 1982;8:1006.
24. Nukada H, Dyck PJ. Neovascularization after ischemic nerve injury. Exp Neurol 1986;92:391–397.
25. McManis PG, Low PA. Factors affecting the relative viability of centrifascicular and subperineurial axons in acute peripheralnerve ischemia. Exp Neurol 1988,99:84–95.
26. Sladky JT, Greenberg JH, Brown MJ. Regional perfusion in normal and ischemic rat sciatic nerves. Ann Neurol 1985;17:191–195.
27. Sladky JT, Greenberg JH, Brown MJ. Enhanced 2-deoxyglucose incorporation in peripheral nerve during ischemia. Brain Res 1987;414:323–329.
28. Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Rrain 1987;110:843–853.
29. Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neuropathy in primary Sjögren’s syndrome. Neurology (in press).
30. McLeod JG, Walsh JC, Pollard JD. Neuropathies associated with paraproteinemias and dysproteinemias. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, 2nd ed., vol 2. Philadelphia: W.B. Saunders, 1984:1847–1865.
31. Dyck PJ, Brown M, Greene D, et al. Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy? Ann Neurol 1986,19:288–290.
32. Dyck PJ, Lambert EH, Windebank AJ, et al. Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol 1981;71:507–514.
33. Woltman HW, Wilder RM. Diabetes mellitus: pathological changes in the spinal cord and peripheral nerves. Arch Intern Med 1929;44:576–603.
34. Fagerberg S-E. Diabetic neuropathy: a clinical and histological study on the signiiicance of vascular affections. Acta Med Scand 1959;164(Suppl 345):5–81.
35. Aagenaes Ö, Moe H. Light- and electron-microscopic study of skin capillaries of diabetics. Diabetes 1961;10:253–259.
36. Vital C, Le Blanc M, Vallat JM, Coquet M, Vallat M, Roques JC. Etude ultrastructurale du nerf pbriphbrique chez 16 diabbtiques sans neuropathie clinique: comparisons avec 16 neuropathies diabbtiques et 16 neuropathies non diabbtiques. Ada Neuropathol (Berl) 1974;30:63–72.
37. Siperstein MD, Unger RH, Madieon LL. Studies of muscle capillary basement membranes in normal subjects, diabetic and prediabetic patients. J Clin Invest 1968,47:1973–1999.
38. Beh F, Buchthal F, Carlaen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40:1072–1082.
39. Downie AW, Newell DJ. Sensory nerve conduction in patients with diabetes mellitue and controls. Neurology 1961;11:876–882.
40. Winegrad AI, Simmons DA. Energy metabolism in peripheral nerve. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr., eds. Diabetic neumpathy. Philadelphia: W.B. Saunders, 1987:279–288.
41. Greene DA, Lattimer SA. Altered myo-inositol metabolism in diabetic nerve. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr., eds. Diabetic neuropathy. Philadelphia: W.B. Saunders, 1987:289–298.
42. Sima AAF, Brismar T, Yagihashi S. Neuropathies encountered in the spontaneously diabetic BB Wistar rat. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr., eds. Diabetic neuropathy. Philadelphia: W.B. Saunders, 1987:253–259.
43. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590–596.
44. Dyck PJ, Zimmennan BR, Vilen TH, et al. Nerve glucose, fructose, sorbitol and myo-inoeitol content and fiber degeneration and regeneration in human diabetic neuropathy. N Engl J Med (in Press).
45. Gregersen G, Barsting H, Theil P, Servo C. Myoinositol and function of peripheral nerves in human diabetics: a controlled clinical trial. Acta Neurol Scand 1978;58:241–248.
46. Sidenius P, Jakobaen J. Axonal transport in human and experimental diabetes. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr., eds. Philadelphia: W.B. Saunders, 1987:260–265.
47. Brimijoin WS. Abnormalities of axonal transport are they a cause of peripheral nerve disease? Mayo Clin Proc 1982;57:707–714.
48. Brimijoin S. The role of axonal transport in nerve disease. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, 2nd ed., vol 1. Philadelphia: W.B. Saunders, 1984:477–493.
49. Sugimura K, Dyck PJ. Sural nerve myelin thickness and axis cylinder caliber in human diabetes. Neurology 1981;31:1087–1091.
50. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168–188 (part 1), 252–263 (part 2).
51. Dyck PJ, Kames J, O’Brien P, Nukada H, Lab A, Low P. Spatial pattern of nerve fiber abnormality indicative of pathologic mechanisms. Am J Pathol 1984,117:225–238.
52. Dyck PJ, Kames JL, O’Brien P, Okazaki H, Lais A, Engelatad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests iachemia. Ann Neurol 1986; 19:440–449.
53. Dyck PJ, Lais A, Kames JL, O’Brien P, Rizza R. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986,19:425–439.
54. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984;107:935–950.
55. Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 1984;81:6894–6898.
56. Low PA, Schmelzer JD, Ward KK, Yao JK. Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 1986;250:E94–E99.
57. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD. Sural nerve oxygen tension in diabetes. Br Med J 1986;293:1053–1054.
58. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 1982;22:6–8.
59. Klemen UM, Freyler H. Arteriovenöse Kurzschlussgefässe der diabetischen Praretinopathie. Klin Monatsbl Augenheilkd 1980;176:956–959.
60. Bohlen HG. Tiesue Po2 in the intestinal muscle layer of rats during chronic diabetes. Circ Res 1983;52:677–682.
61. Kiesewetter H, Jung F, Korber N, et al. Microcirculation and hemorheology of children with type I diabetes. Klin Wochenschr 1986;64:962–968.
62. Barnes AJ, Lake P, Scudder PR, Dormandy TL, Dormandy JA, Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet 1977;2:789–791.
63. Baba Y, Kai M, Kamada T, Setoyama S, Otsuji S. Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes 1979;28:1138–1140.
64. McMillan DE. Further observations on serum viscosity change in diabetes mellitus. Metabolism 1982;31:274–278.
65. McMillan DE, Utterback NG, La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes 1978;27:895–901.
66. Satoh M, Imaizumi K, Bessho T, Shiga T. Increased erythrocyte aggregation in diabetes mellitus and its relationship to glycosylated haemoglobin and retinopathy. Diabetologia 1984;27:517–521.
67. Wautier J-L, Paton RC, Wautier MP, et al. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 1981;305:237–242.
68. Schmid-Schonbein H, Volger E. Red-cell aggregation and red-cell deformability in diabetes. Diabetes 1976;25(suppl 2):897–902.
69. Poon PY, Dornan TL, Orde-Peckar C, Mullins R, Bron AJ, Turner RC. Blood viscosity, glycaemic control and retinopathy in insulin-dependent diabetes. Clin Sci 1982;63:211–216.
70. Trope GE, Lowe GDO, Ghafour IM, Foulds WS, Forbes CD. Blood viscosity in proliferative diabetic retinopathy and complicated retinal vein thrombosis. Trans Ophthalmol SOC UK 1983;103:108–110.
71. Diamantopoulos EJ, Raptis SA, Moulopoulos SD. Red blood-cell deformability index in diabetic-retinopathy. Horm Metab Res 1987;19:569–573.
72. Juhan-Vague I, Roul C, Rahmani-Jourdheil D, et al. Rapid modifications of biophysical and biochemical parameters of red blood cell membrane from insulin dependent diabetics after insulin administration. Klin Wochenschr 1986;64:1046–1049.
73. Robey C, Dasmahapatra A, Cohen MP, Suarez S. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus. Diabetes 1987;36:1010–1013.
74. Ferrari E, Fioravanti M, Patti AL, Viola C, Solerte SB. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients. Phannatherapeutica 1987:5:26–39.
75. Antignani PL, Todini AR, Saliceti F, Pacino G, Bartolo M. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses. Pharmatherapeutica 1987;5:50–56.
76. Solerte SB, Ferrari E. Diabetic retinal vascular complications and erythrocyte filtrability: reaulta of a 2-year follow-up study with pentoxifylline. Pharmatherapeutica 1985;4:341–350.
77. Dyck PJ, Hansen S, Kames J, et al. Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 1985,82:2513–2517.
78. Yasuda H, Dyck PJ. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987;37:20–28.
79. Pongor S, Ulrich PC, Bencsath FA, Cerami A. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc Natl Acad Sci USA 1984;81:2684–2688.
80. Brownlee M, Vlaasara H, Cerami A. Nonenzymatic glymylation and the pathogenesis of diabetic complications. Ann Intern Med 1986;101:527–537.
81. Ohi T, Poduslo JF, Curran GL, Dyck P J. Quantitative method for detection of blood-nerve barrier alterations in experimental animal models of neuropathy. Exp Neurol 1985;90:365–372.
82. Poduslo JF, Curran GL, Brunden KR, Dyck PJ. IgM/IgG solid-phase antibody-capture assay with biotin/125I-streptavidin amplification: application to normal human sural nerve biopsies. J Neuroimmunol 1988;18:117–124.
83. Poduslo JF, Curran GL, Dyck PJ. Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy. Proc Natl Acad Sci USA (in press).
84. Spencer PS, Weinberg HJ, Raine CS, Prineas JW. The peri-neurial window: a new model of focal demyelination and remyelination. Brain Res 1975;96:323–329.